Masayo Oishi
Astellas Pharma (Japan)(JP)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Computational Drug Discovery Methods, Retinal Diseases and Treatments, Cancer Cells and Metastasis
Most-Cited Works
- → Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation(2018)71 cited
- → Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm(2020)70 cited
- → Modeling of Blood–Brain Barrier (BBB) Dysfunction and Immune Cell Migration Using Human BBB-on-a-Chip for Drug Discovery Research(2024)22 cited
- → Effect of the CYP2D6*10 Genotype on Tolterodine Pharmacokinetics(2010)15 cited
- → A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations(2014)12 cited
- → Pharmacokinetics of Tolterodine in Japanese and Koreans: Physiological and Stochastic Assessment of Ethnic Differences(2011)10 cited
- → Physiological based pharmacokinetic modeling to estimate in vivo Ki of ketoconazole on renal P-gp using human drug-drug interaction study result of fesoterodine and ketoconazole(2017)9 cited
- → Population pharmacokinetics of the 5‐hydroxymethyl metabolite of tolterodine after administration of fesoterodine sustained release tablet in western and east Asian populations(2014)6 cited
- → Practical QSP application from the preclinical phase to enhance the probability of clinical success: Insights from case studies in oncology(2024)5 cited
- → Different Truncation Methods of AUC between Japan and the EU for Bioequivalence Assessment: Influence on the Regulatory Judgment(2012)2 cited